C2i Genomics is Decision/Risk Analysis in United States that focus on disease recurrence business. Founded in 2019. They cover business area such as developer, diagnostic technology, cancer patient life, outcome, cancer recurrence, physician, patient treatment response, treatment failure, disease recurrence, subtle change, oncologist, vital timely information month, year, current monitoring method.
2019
( 5 years old in 2024 )
Disease Recurrence
-
180 Varick Street
6th Floor
New York, NY 10014
United States
Private
developerdiagnostic technologycancer patient lifeoutcomecancer recurrencephysicianpatient treatment responsetreatment failuredisease recurrencesubtle changeoncologistvital timely information monthyearcurrent monitoring method
* We use standard office opening hours in near C2i Genomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
C2i Genomics is Decision/Risk Analysis business from United States that founded in 2019 (5 years old in 2024), C2i Genomics business is focusing on Disease Recurrence.
C2i Genomics headquarter office and corporate office address is located in 180 Varick Street 6th Floor New York, NY 10014 United States.
C2i Genomics was founded in United States.
In 2024, C2i Genomics is currently focus on disease recurrence sector.
Above is snippet of Google Trends for "disease recurrence" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with C2i Genomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
